AHRMM On-Demand Webinar: Partnering for Savings: How Hospitals Are Benefiting from Mark Cuban Cost Plus Drug Company

Description

Overview:

Join the American Hospital Association (AHA) and The Association for Health Care Resource & Materials Management (AHRMM) for a panel discussion about the Mark Cuban Cost Plus Drug Company’s approach to drug pricing. Learn tangible examples of how hospital and health system peers have partnered with Cost Plus to achieve significant savings and transparency in drug purchasing.

Learning Objectives:

• Overview of the Model: Understand the unique business model of the Mark Cuban Cost Plus Drug Company.
• Partnership Strategies: Explore how the company collaborates with hospitals and health systems to implement their pricing model, ensuring that these institutions can offer affordable medications to their patients.
• Transparency Benefits: Discuss the benefits of increased transparency in drug spending, such as better budgeting, improved supply chain management, and enhanced patient care.
• Lessons Learned: Gain insights from the experiences of health care system leaders, including best practices and lessons learned in the process of adopting new drug purchasing strategies.

Speakers:

• Alex Oshmyansky, M.D., PhD, CEO and Co-Founder, Mark Cuban Cost Plus Drug Company
• Alan Bowe, Chief Commercial Officer, Mark Cuban Cost Plus Drug Company
• Tyson Frodin, PharmD, MHA, FACHE, Assistant Vice President, Pharmacy Supply Chain, Rev Cycle & Technology, MultiCare Health System
• Nishaminy Kasbekar, BS, PharmD, FASHP, Vice President of Pharmacy Services and Chief Pharmacy Officer, Penn Medicine and University of Pennsylvania Health System

Moderated by:

• Michelle Hood, FACHE, Executive Vice President and Chief Operating Officer, AHA
• Mike Schiller, FAHRMM, CMRP, Executive Director, Association for Health Care Resource & Materials Management (AHRMM) of the AHA